June 28-30, 2023
Kyoto Tokyu Hotel
Kyoto, Japan

Visit Conference Website

Registration Deadline for Abstract Submitters: Wednesday, April 26, 2023 (10:59 A.M. EDT)

Registration Deadline (without abstract submission: Thursday, May 25, 2023 (10:59 A.M. EDT)

Virtual Registration Deadline: Friday, June 23, 2023 (10:59 A.M. EDT)

Registration Details

The inaugural conference was held in September 2021 in a virtual format. The 2^nd conference will be held in June 2023, and then every two to three years in Japan. This collaboration between the JCA and AACR will bring together the greatest minds from the United States, Japan, and around the world to share the latest and most exciting developments in precision cancer medicine.

View Program

Program Topics:

• Advances in T-cell biology
• Premalignancy and its detection
• Microbiome and cancer
• RNA as a target
• Novel targets brought by genomics/epigenomics
• Revolution in diagnosis and clinical trials
• Inflammation and cancer
• Computational biology

Conference Cochairs

Hiroyoshi Nishikawa, National Cancer Center Research Institute, Tokyo, Japan 
Charles Swanton, The Francis Crick Institute, London, United Kingdom 

Organizing Committee 

Nina Bhardwaj, Icahn School of Medicine at Mount Sinai, New York, NY, USA 
Trever G. Bivona, University of California San Francisco, San Francisco, CA, USA 
Maximilian Diehn, Stanford University, Stanford, CA, USA 
Elana J. Fertig, Johns Hopkins University, Baltimore, MD, USA 
Dean Ho, National University of Singapore, Singapore 
Daichi Inoue, Institute of Biomedical Research and Innovation, Kobe City, Japan 
Nada Jabado, McGill University, Montreal, QC, Canada 
Hiroyuki Mano, National Cancer Center Research Institute, Tokyo, Japan 
Matthew L. Meyerson, Dana-Farber Cancer Institute, Boston, MA, USA 
Hitomi Okuma, National Cancer Center Hospital, Tokyo, Japan 
Naoko Otani, Osaka Metropolitan University, Osaka, Japan 
Mamiko Sakata-Yanagimoto, University of Tsukuba, Tsukuba, Japan